Taiwan FDA registration 24218209a103b3c07cc9bef80c3cd9e8
GSP Neonatal G6PD Kit
TW: 豐技新生兒葡萄糖6磷酸鹽去氫酶缺乏症檢測套組
Taiwan·Risk Class 2·MD·WALLAC OY·Registered Nov 05, 2019 – Nov 05, 2024ExpiredRegistration details
- Analysis ID
- 24218209a103b3c07cc9bef80c3cd9e8
- License Form
- Ministry of Health Medical Device Import No. 032958
- Customs Code
- DHA05603295809
Company information
- Manufacturer
- WALLAC OY
- Manufacturer Country
- Finland
- Authorized Representative
- FENG CHI BIOTECH CORP.
Product details
- Intended Use
- This product is used with GSP instrument to quantitatively determine the glucose 6 phosphate dehydrogenase (G6PD) content on dried blood spot samples.
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B7360 Analysis of glucose-6-phosphate hydrolytic enzyme for red blood cells
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Nov 05, 2019
- Expiry Date
- Nov 05, 2024
About this record
Access comprehensive regulatory information for GSP Neonatal G6PD Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 24218209a103b3c07cc9bef80c3cd9e8 and manufactured by WALLAC OY. The authorized representative in Taiwan is FENG CHI BIOTECH CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices